Cancer BiologybioRxiv
Activation of retinoic acid receptor reduces metastatic prostate cancer bone lesions through blocking endothelial-to-osteoblast transition
DOI 10.1158/0008-5472.can-22-0170
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
2 papers
Recent·Most cited
S.-H. Lin, Y.-C. Lee, S.-C. Lin…·L.-y. Yu-Lee
This study shows that prostate tumor-induced stromal reprogramming produces Tenascin C, which promotes metastasis by inhibiting YAP/TAZ through 5{beta}1 integrin.